Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets

被引：0
|
作者：
Flamm, S. [1 ]
Charlton, M. [2 ]
Manns, M. [3 ]
Prieto, M. [4 ]
Fernandez, I. [5 ]
Londono, M. [6 ]
Kwok, R. [7 ]
Smith, C. [8 ]
Lee, S. [9 ]
Ngo, H. [9 ]
Osinusi, A. [9 ]
Copans, A. [9 ]
Rossaro, L. [9 ]
Shoreibah, M. [10 ]
Massoud, O. [10 ]
Curry, M. [11 ]
Bourliere, M. [12 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Intermt Med Ctr, Murray, KY USA
[3] Hannover Med Sch, Hannover, Germany
[4] Hosp Univ I Politecn La Fe, Valencia, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Hosp Clin Barcelona, Serv Hepatol, Barcelona, Spain
[7] Walter Reed Natl Mil Med Ctr, Washington, DC USA
[8] Medstar Georgetown Univ Hosp, Georgetown, Guyana
[9] Gilead Sci Inc, Foster City, CA USA
[10] Univ Alabama Birmingham, Birmingham, AL USA
[11] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[12] Hosp St Joseph, Marsielle, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
145
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of ledipasvir/sofosbuvir ± ribavirin in the treatment of HCV infection: The real-world HARVEST study
    Flisiak, Robert
    Lucejko, Mariusz
    Mazur, Wlodzimierz
    Janczewska, Ewa
    Berak, Hanna
    Tomasiewicz, Krzysztof
    Mozer-Lisewska, Iwona
    Kozielewicz, Dorota
    Gietka, Andrzej
    Sikorska, Katarzyna
    Wawrzynowicz-Syczewska, Marta
    Nowak, Krzysztof
    Zarebska-Michaluk, Dorota
    Musialik, Joanna
    Simon, Krzysztof
    Garlicki, Aleksander
    Plesniak, Robert
    Baka-Cwierz, Barbara
    Olszok, Iwona
    Augustyniak, Krystyna
    Stolarz, Wojciech
    Bialkowska, Jolanta
    Badurek, Anna
    Piekarska, Anna
    ADVANCES IN MEDICAL SCIENCES, 2017, 62 (02): : 387 - 392
  • [22] Sofosbuvir-ledipasvir with or without ribavirin for chronic hepatitis C genotype-1 and 6: real-world experience in Vietnam
    Pham Thi Thu Thuy
    Bunchorntavakul, Chalermrat
    Ho Tan Dat
    Palecki, Julia
    Reddy, K. Rajender
    ANTIVIRAL THERAPY, 2018, 23 (05) : 415 - 423
  • [23] Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease
    Rockstroh, Juergen K.
    Ingiliz, Patrick
    Petersen, Joerg
    Peck-Radosavljevic, Markus
    Welzel, Tania M.
    Van der Valk, Marc
    Zhao, Yue
    Jimenez-Exposito, Maria Jesus
    Zeuzem, Stefan
    ANTIVIRAL THERAPY, 2017, 22 (03) : 225 - 236
  • [24] Real-world efficacy of sofosbuvir and daclatasvir, with and without ribavirin for patients with chronic hepatitis C in Asia
    Chirapongsathorn, Sakkarin
    Wongpaitoon, Virasak
    Phanubol, Patamaporn
    Techapaitoon, Satien
    Sukhabote, Rujapong
    Osangthamnont, Charkaphan
    Anuras, Sinn
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 163 - 163
  • [25] Evaluation of Proton Pump Inhibitor Use on Treatment Outcomes With Ledipasvir and Sofosbuvir in a Real-World Cohort Study
    Tapper, Elliot B.
    Bacon, Bruce R.
    Curry, Michael P.
    Dieterich, Douglas T.
    Flamm, Steven L.
    Guest, Lauren E.
    Kowdley, Kris V.
    Lee, Yoori
    Tsai, Naoky C.
    Younossi, Zobair M.
    Afdhal, Nezam H.
    HEPATOLOGY, 2016, 64 (06) : 1893 - 1899
  • [26] High Efficacy of Sofosbuvir/Ledipasvir Without Ribavirin in Patients With HCV Recurrence After Liver Transplantation
    Elfeki, Mohamed A.
    Abou Mrad, Rachel
    Esfeh, Jamak Modaresi
    Zein, Nizar N.
    Eghtesad, Bijan
    Hanouneh, Ibrahim A.
    Alkhouri, Naim
    GASTROENTEROLOGY, 2016, 150 (04) : S1098 - S1098
  • [27] Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection
    Sulkowski, Mark S.
    Vargas, Hugo E.
    Di Bisceglie, Adrian M.
    Kuo, Alexander
    Reddy, K. Rajender
    Lim, Joseph K.
    Morelli, Giuseppe
    Darling, Jama M.
    Feld, Jordan J.
    Brown, Robert S.
    Frazier, Lynn M.
    Stewart, Thomas G.
    Fried, Michael W.
    Nelson, David R.
    Jacobson, Ira M.
    GASTROENTEROLOGY, 2016, 150 (02) : 419 - 429
  • [28] Post-Liver Transplant Treatment of Hepatitis C with a combination of Sofosbuvir, Simeprevir, ± Ribavirin at a High Volume Academic Transplant Center
    Ford, Ryan M.
    Pillai, Anjana
    Cheng, Nicole
    Young, Nikita M.
    Parekh, Samir
    Norvell, J. P.
    Subramanian, Ram
    Spivey, James
    HEPATOLOGY, 2014, 60 : 701A - 701A
  • [29] Outcome of Recurrent Hepatitis C Treatment in Post Liver and Liver/Kidney Transplant Patients Treated with Ledipasavir/Sofosbuvir with and without Ribavirin or Sofosbuvir with Ribavirin: Single Center Experience
    Selim, Khaled
    Elhazin, Bridgeida
    Long, Wen
    Salazar, Jennifer
    Karmanova, Marina
    Volk, Micheal
    TRANSPLANTATION, 2016, 100 : S124 - S124
  • [30] Large Single-Center Experience of Sofosbuvir and Ledipasvir Therapy for the Treatment of Post-Liver Transplant Patients with Hepatitis C Virus.
    Wedd, J.
    Ford, R.
    Norvell, J.
    Parekh, S.
    Cheng, N.
    Young, N.
    Patel, A.
    Maheshwari, R.
    Vora, R.
    Mgbemena, O.
    Spivey, J.
    Pillai, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 298 - 298
12345